Patents by Inventor Terry T. Kensler

Terry T. Kensler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lyophilized cyclophosphamide
    Patent number: 5413995
    Abstract: A lyophilized pharmaceutical solid composition containing cyclophosphamide for reconstitution with water to provide a solution for oral or parenteral administration. This lyophilized cyclophosphamide solid composition demonstrates improved stability, solubility characteristics and enhanced appearance compared with currently available dry powder pre-mix compositions of cyclophosphamide. The lyophilized solid composition contains about 20 parts by weight of cyclophosphamide, about 11/4-2 parts by weight of water and from about 10-85 parts by weight of excipient which is comprised mainly of mannitol. Processes for making the composition are disclosed.
    Type: Grant
    Filed: March 8, 1985
    Date of Patent: May 9, 1995
    Assignee: Mead Johnson & Company
    Inventors: Robert L. Alexander, Robert J. Bequette, Terry T. Kensler, Joseph A. Scott
  • Lyophilized cyclophosphamide
    Patent number: 5227374
    Abstract: A lyophilized pharmaceutical solid composition containing cyclophosphamide for reconstitution with water to provide a solution for oral or parenteral administration. This lyophilized cyclophosphamide solid composition demonstrates improved stability, solubility characteristics and enhanced appearance compared with currently available dry powder pre-mix compositions of cyclophosphamide. The lyophilized solid composition contains about 20 parts by weight of cyclophosphamide, about 11/4-2 parts by weight of water and from about 10-85 parts by weight of excipient which is comprised mainly of mannitol. Processes for making the composition are disclosed.
    Type: Grant
    Filed: December 23, 1991
    Date of Patent: July 13, 1993
    Assignee: Mead Johnson & Company
    Inventors: Robert L. Alexander, Robert J. Bequette, Terry T. Kensler, Joseph A. Scott
  • Process for buspirone hydrochloride polymorphic crystalline form conversion
    Patent number: 4810789
    Abstract: A process for conversion of one polymorphic crystalline form of buspirone into its other polymorphic crystalline form.
    Type: Grant
    Filed: August 28, 1987
    Date of Patent: March 7, 1989
    Assignee: Bristol-Myers Company
    Inventors: Robert J. Behme, Terry T. Kensler, Douglas G. Mikolasek
  • Lyophilized cyclophosphamide
    Patent number: 4537883
    Abstract: A lyophilized pharmaceutical solid composition containing cyclophosphamide for reconstitution with water to provide a solution for oral or parenteral administration. This lyophilized cyclophosphamide solid composition demonstrates improved stability, solubility characteristics and enhanced appearance compared with currently available dry powder pre-mix compositions of cyclophosphamide. The lyophilized solid composition contains about 20 parts by weight of cyclophosphamide, about 11/4-2 parts by weight of water and from about 10-85 parts by weight of excipient which is comprised mainly of mannitol. Processes for making the composition are disclosed.
    Type: Grant
    Filed: March 13, 1984
    Date of Patent: August 27, 1985
    Assignee: Mead Johnson & Company
    Inventors: Robert L. Alexander, Robert J. Bequette, Terry T. Kensler, Joseph A. Scott